PRICE T ROWE ASSOCIATES INC /MD/ - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 102 filers reported holding MAXCYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$59
-29.8%
18,797
+3.7%
0.00%
Q2 2023$84
+1.2%
18,123
+9.0%
0.00%
Q1 2023$830.0%16,629
+9.6%
0.00%
Q4 2022$83
-99.9%
15,174
+12.5%
0.00%
Q3 2022$88,000
-66.0%
13,493
-63.6%
0.00%
Q1 2022$259,000
-95.4%
37,018
-93.4%
0.00%
-100.0%
Q4 2021$5,674,000
-7.3%
556,816
+11.1%
0.00%0.0%
Q3 2021$6,121,000501,3220.00%
Other shareholders
MAXCYTE INC shareholders Q4 2021
NameSharesValueWeighting ↓
NORTH RUN CAPITAL, LP 480,900$3,361,0004.94%
Casdin Capital, LLC 13,971,334$97,660,0004.38%
Vitruvian Partners LLP 4,385,670$30,656,0003.25%
RIVER GLOBAL INVESTORS LLP 2,100,000$14,849,0001.95%
APIS CAPITAL ADVISORS, LLC 180,000$1,258,0001.52%
Pier Capital, LLC 1,017,753$7,114,0000.91%
First Light Asset Management, LLC 1,321,406$9,237,0000.82%
Montanaro Asset Management Ltd 929,000$6,557,0000.81%
Nicholas Investment Partners, LP 776,963$5,431,0000.39%
Bleichroeder LP 250,000$1,764,0000.31%
View complete list of MAXCYTE INC shareholders